PLSE vs. SMMT
PLSE (Pulse Biosciences, Inc.) and SMMT (Summit Therapeutics Inc.) are both stocks. Both are in the Healthcare sector — PLSE in Medical Instruments & Supplies, SMMT in Biotechnology. Over the past 10 years, PLSE returned 19.02%/yr vs 5.76%/yr for SMMT. At a 0.15 correlation, their price movements are largely independent.
Performance
PLSE vs. SMMT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PLSE achieves a 82.01% return, which is significantly higher than SMMT's -13.84% return. Over the past 10 years, PLSE has outperformed SMMT with an annualized return of 19.02%, while SMMT has yielded a comparatively lower 5.76% annualized return.
PLSE
- 1D
- 2.92%
- 1M
- 24.76%
- YTD
- 82.01%
- 6M
- 85.25%
- 1Y
- 41.75%
- 3Y*
- 57.47%
- 5Y*
- 6.15%
- 10Y*
- 19.02%
SMMT
- 1D
- 1.41%
- 1M
- -11.25%
- YTD
- -13.84%
- 6M
- -17.96%
- 1Y
- -26.92%
- 3Y*
- 102.68%
- 5Y*
- 13.50%
- 10Y*
- 5.76%
PLSE vs. SMMT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
PLSE Pulse Biosciences, Inc. | 82.01% | -21.14% | 42.24% | 341.88% | -81.30% | -37.93% | 77.93% | 17.02% | -51.44% | 263.08% |
SMMT Summit Therapeutics Inc. | -13.84% | -1.99% | 583.72% | -38.59% | 57.99% | -42.77% | 193.75% | 39.13% | -89.62% | 29.44% |
Correlation
The correlation between PLSE and SMMT is 0.27, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.27 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.21 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.21 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.15 |
Correlation (All Time) Calculated using the full available price history since May 19, 2016 | 0.15 |
The correlation between PLSE and SMMT shifts across timeframes, from 0.15 (all time) to 0.27 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
PLSE:
$1.69B
SMMT:
$11.69B
PLSE:
-$1.11
SMMT:
-$1.60
PLSE:
25.55
SMMT:
21.41
PLSE:
$751.00K
SMMT:
$0.00
PLSE:
-$684.00K
SMMT:
-$83.36K
PLSE:
-$73.79M
SMMT:
-$738.34M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PLSE vs. SMMT — Risk / Return Rank
PLSE
SMMT
PLSE vs. SMMT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Pulse Biosciences, Inc. (PLSE) and Summit Therapeutics Inc. (SMMT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PLSE | SMMT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.85 | ||
| Sortino ratioReturn per unit of downside risk | +1.60 | ||
| Omega ratioGain probability vs. loss probability | 1.19 | 1.00 | +0.19 |
| Calmar ratioReturn relative to maximum drawdown | 1.15 | -0.51 | +1.66 |
| Martin ratioReturn relative to average drawdown | 2.21 | -0.80 | +3.00 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| PLSE | SMMT | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.49 | -0.36 | +0.85 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.06 | 0.07 | -0.01 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.21 | 0.04 | +0.17 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.21 | 0.03 | +0.19 |
Drawdowns
PLSE vs. SMMT - Drawdown Comparison
The maximum PLSE drawdown since its inception was -97.22%, roughly equal to the maximum SMMT drawdown of -95.75%. Use the drawdown chart below to compare losses from any high point for PLSE and SMMT.
Loading charts...
Drawdown Indicators
| PLSE | SMMT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.22% | -95.75% | -1.47% |
Max Drawdown (1Y)Largest decline over 1 year | -36.51% | -52.76% | +16.25% |
Max Drawdown (3Y)Largest decline over 3 years | -55.90% | -62.26% | +6.36% |
Max Drawdown (5Y)Largest decline over 5 years | -95.38% | -91.78% | -3.60% |
Max Drawdown (10Y)Largest decline over 10 years | -97.22% | -95.75% | -1.47% |
Current DrawdownCurrent decline from peak | -43.55% | -58.94% | +15.39% |
Average DrawdownAverage peak-to-trough decline | -59.75% | -57.64% | -2.11% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 19.04% | 33.88% | -14.84% |
Volatility
PLSE vs. SMMT - Volatility Comparison
Pulse Biosciences, Inc. (PLSE) has a higher volatility of 28.86% compared to Summit Therapeutics Inc. (SMMT) at 22.87%. This indicates that PLSE's price experiences larger fluctuations and is considered to be riskier than SMMT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PLSE | SMMT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 28.86% | 22.87% | +5.99% |
Volatility (6M)Calculated over the trailing 6-month period | 69.05% | 56.77% | +12.28% |
Volatility (1Y)Calculated over the trailing 1-year period | 84.91% | 77.69% | +7.22% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 97.99% | 185.11% | -87.12% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 91.70% | 144.64% | -52.94% |
Dividends
PLSE vs. SMMT - Dividend Comparison
Neither PLSE nor SMMT has paid dividends to shareholders.
Financials
PLSE vs. SMMT - Financials Comparison
This section allows you to compare key financial metrics between Pulse Biosciences, Inc. and Summit Therapeutics Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
PLSE and SMMT have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
PLSE has higher volatility (28.86%) compared to SMMT (22.87%). In terms of maximum drawdown, PLSE dropped -97.22% vs SMMT's -95.75%.
PLSE currently has the higher Sharpe Ratio (0.49 vs -0.36), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PLSE and SMMT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer